Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CTAD 2022 | Can the APOEε4 genotype contribute to tau pathology progression?

João Pedro Ferrari-Souza, MD-PhD student, University of Pittsburgh, Pittsburgh, shares insights into his current work investigating how the APOEε4 genotype and amyloid-β associate with each other and how this contributes to tau pathology progression. This interview took place at the Clinical Trials on Alzheimer’s Disease congress 2022 in San Francisco.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.